| A viral movement protein prevents spread of the gene silencing signal in Nicotiana benthamiana O Voinnet, C Lederer, DC Baulcombe Cell 103 (1), 157-167, 2000 | 875 | 2000 |
| IthaGenes: an interactive database for haemoglobin variations and epidemiology P Kountouris, CW Lederer, P Fanis, X Feleki, J Old, M Kleanthous PloS one 9 (7), e103020, 2014 | 272 | 2014 |
| Turnip crinkle virus coat protein mediates suppression of RNA silencing in Nicotiana benthamiana CL Thomas, V Leh, C Lederer, AJ Maule Virology 306 (1), 33-41, 2003 | 269 | 2003 |
| Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis CW Lederer, A Torrisi, M Pantelidou, N Santama, S Cavallaro BMC genomics 8, 1-26, 2007 | 194 | 2007 |
| The dialogue between viruses and hosts in compatible interactions A Maule, V Leh, C Lederer Current opinion in plant biology 5 (4), 279-284, 2002 | 161 | 2002 |
| Virus induction of heat shock protein 70 reflects a general response to protein accumulation in the plant cytosol F Aparicio, CL Thomas, C Lederer, Y Niu, D Wang, AJ Maule Plant physiology 138 (1), 529-536, 2005 | 159 | 2005 |
| Recent trends in the gene therapy of β-thalassemia A Finotti, L Breda, CW Lederer, N Bianchi, C Zuccato, M Kleanthous, ... Journal of blood medicine, 69-85, 2015 | 140 | 2015 |
| Gene silencing methods DC Baulcombe, O Voinnet, CW Lederer US Patent 6,531,647, 2003 | 131 | 2003 |
| Bone marrow as an alternative site for islet transplantation E Cantarelli, R Melzi, A Mercalli, V Sordi, G Ferrari, CW Lederer, E Mrak, ... Blood, The Journal of the American Society of Hematology 114 (20), 4566-4574, 2009 | 91 | 2009 |
| Rare opportunities: CRISPR/Cas-based therapy development for rare genetic diseases P Papasavva, M Kleanthous, CW Lederer Molecular diagnosis & therapy 23 (2), 201-222, 2019 | 66 | 2019 |
| Plerixafor+G-CSF–mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy G Karponi, N Psatha, CW Lederer, JE Adair, F Zervou, N Zogas, ... Blood, The Journal of the American Society of Hematology 126 (5), 616-619, 2015 | 61 | 2015 |
| The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study P Kountouris, I Kousiappa, T Papasavva, G Christopoulos, E Pavlou, ... Scientific reports 6 (1), 26371, 2016 | 59 | 2016 |
| Differential expression of molecular motors in the motor cortex of sporadic ALS M Pantelidou, SE Zographos, CW Lederer, T Kyriakides, MW Pfaffl, ... Neurobiology of Disease 26 (3), 577-589, 2007 | 59 | 2007 |
| A novel family of katanin-like 2 protein isoforms (KATNAL2), interacting with nucleotide-binding proteins Nubp1 and Nubp2, are key regulators of different MT-based processes in … A Ververis, A Christodoulou, M Christoforou, C Kamilari, CW Lederer, ... Cellular and Molecular Life Sciences 73, 163-184, 2016 | 48 | 2016 |
| KLF10 Gene Expression is Associated with High Fetal Hemoglobin Levels and with Response to Hydroxyurea Treatment in β-Hemoglobinopathy Patients J Borg, M Phylactides, M Bartsakoulia, C Tafrali, C Lederer, AE Felice, ... Pharmacogenomics 13 (13), 1487-1500, 2012 | 46 | 2012 |
| Motor protein KIFC5A interacts with Nubp1 and Nubp2, and is implicated in the regulation of centrosome duplication A Christodoulou, CW Lederer, T Surrey, I Vernos, N Santama Journal of cell science 119 (10), 2035-2047, 2006 | 41 | 2006 |
| Correction of IVS I-110 (G> A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells P Patsali, G Turchiano, P Papasavva, M Romito, CC Loucari, ... Haematologica 104 (11), e497, 2019 | 39 | 2019 |
| Disruptive technology: CRISPR/Cas-based tools and approaches P Patsali, M Kleanthous, CW Lederer Molecular Diagnosis & Therapy 23 (2), 187-200, 2019 | 34 | 2019 |
| Measurement of lentiviral vector titre and copy number by cross-species duplex quantitative PCR I Christodoulou, P Patsali, C Stephanou, M Antoniou, M Kleanthous, ... Gene therapy 23 (1), 113-118, 2016 | 33 | 2016 |
| The nucleotide-binding proteins Nubp1 and Nubp2 are negative regulators of ciliogenesis E Kypri, A Christodoulou, G Maimaris, M Lethan, M Markaki, C Lysandrou, ... Cellular and molecular life sciences 71, 517-538, 2014 | 31 | 2014 |
Marina KleanthousThe Cyprus Institute of Neurology and GeneticsBestätigte E-Mail-Adresse bei cing.ac.cy
